Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

buy Lyrica in uk Share the Post

Bremervörde Related Posts

Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs